144 related articles for article (PubMed ID: 38043717)
1. Puerarin inhibits cisplatin-induced ototoxicity in mice through regulation of TRPV1-dependent calcium overload.
Lin Y; Liang R; Xie K; Ma T; Zhang J; Xu T; Wang A; Liu S
Biochem Pharmacol; 2024 Feb; 220():115962. PubMed ID: 38043717
[TBL] [Abstract][Full Text] [Related]
2. Protective Effect of Avenanthramide-C on Auditory Hair Cells against Oxidative Stress, Inflammatory Cytokines, and DNA Damage in Cisplatin-Induced Ototoxicity.
Umugire A; Nam YS; Nam YE; Choi YM; Choi SM; Lee S; Cho JH; Cho HH
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769271
[TBL] [Abstract][Full Text] [Related]
3. Puerarin attenuates cisplatin-induced apoptosis of hair cells through the mitochondrial apoptotic pathway.
Xu B; Li J; Chen X; Kou M
Biochim Biophys Acta Mol Cell Res; 2022 Apr; 1869(4):119208. PubMed ID: 35032475
[TBL] [Abstract][Full Text] [Related]
4. Puerarin alleviates the ototoxicity of gentamicin by inhibiting the mitochondria‑dependent apoptosis pathway.
Niu P; Sun Y; Wang S; Li G; Tang X; Sun J; Pan C; Sun J
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34651662
[TBL] [Abstract][Full Text] [Related]
5. Ursolic acid protects against cisplatin‑induced ototoxicity by inhibiting oxidative stress and TRPV1‑mediated Ca2+‑signaling.
Di Y; Xu T; Tian Y; Ma T; Qu D; Wang Y; Lin Y; Bao D; Yu L; Liu S; Wang A
Int J Mol Med; 2020 Aug; 46(2):806-816. PubMed ID: 32626955
[TBL] [Abstract][Full Text] [Related]
6. An enhanced antioxidant strategy of astaxanthin encapsulated in ROS-responsive nanoparticles for combating cisplatin-induced ototoxicity.
Gu J; Wang X; Chen Y; Xu K; Yu D; Wu H
J Nanobiotechnology; 2022 Jun; 20(1):268. PubMed ID: 35689218
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Protein arginine methyltransferase 6 reduces reactive oxygen species production and attenuates aminoglycoside- and cisplatin-induced hair cell death.
He Y; Li W; Zheng Z; Zhao L; Li W; Wang Y; Li H
Theranostics; 2020; 10(1):133-150. PubMed ID: 31903111
[TBL] [Abstract][Full Text] [Related]
8. Evaluating protective and therapeutic effects of alpha-lipoic acid on cisplatin-induced ototoxicity.
Kim KH; Lee B; Kim YR; Kim MA; Ryu N; Jung DJ; Kim UK; Baek JI; Lee KY
Cell Death Dis; 2018 Aug; 9(8):827. PubMed ID: 30068942
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of apocynin on cisplatin-induced ototoxicity in an auditory cell line and in zebrafish.
Choi J; Im GJ; Chang J; Chae SW; Lee SH; Kwon SY; Chung AY; Park HC; Jung HH
J Appl Toxicol; 2013 Feb; 33(2):125-33. PubMed ID: 22147442
[TBL] [Abstract][Full Text] [Related]
10. Deciphering the potential ability of RG108 in cisplatin-induced HEI-OC1 ototoxicity: a research based on RNA-seq and molecular biology experiment.
Zhang D; Sun Y; Lei M; Wang Y; Cai C
Hereditas; 2023 Apr; 160(1):18. PubMed ID: 37088824
[TBL] [Abstract][Full Text] [Related]
11. C-phycocyanin from
Kim YR; Do JM; Kim KH; Stoica AR; Jo SW; Kim UK; Yoon HS
Mar Drugs; 2019 Apr; 17(4):. PubMed ID: 31010222
[TBL] [Abstract][Full Text] [Related]
12. Ginkgolide B protects against cisplatin-induced ototoxicity: enhancement of Akt-Nrf2-HO-1 signaling and reduction of NADPH oxidase.
Ma W; Hu J; Cheng Y; Wang J; Zhang X; Xu M
Cancer Chemother Pharmacol; 2015 May; 75(5):949-59. PubMed ID: 25749575
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of 1,2,3-triazole derivative KPR-A020 against cisplatin-induced ototoxicity in murine cochlear cultures.
Kim YR; Jung DJ; Oh SK; Lee T; Lee IK; Lee KY; Kim UK
Int J Pediatr Otorhinolaryngol; 2017 May; 96():59-64. PubMed ID: 28390615
[TBL] [Abstract][Full Text] [Related]
14. 20(S)-Ginsenoside Rh1 inhibits cisplatin-induced hearing loss by inhibiting the MAPK signaling pathway and suppressing apoptosis in vitro.
Qiao X; He Y; Li W; Liu C; Yang J; Li H
Biochim Biophys Acta Mol Cell Res; 2023 Jun; 1870(5):119461. PubMed ID: 36931607
[TBL] [Abstract][Full Text] [Related]
15. The expression of copper transporters associated with the ototoxicity induced by platinum-based chemotherapeutic agents.
Perde-Schrepler M; Fischer-Fodor E; Virag P; Brie I; Cenariu M; Pop C; Valcan A; Gurzau E; Maniu A
Hear Res; 2020 Mar; 388():107893. PubMed ID: 32006874
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of CISD1 attenuates cisplatin-induced hearing loss in mice via the PI3K and MAPK pathways.
Dong W; Jiang Y; Yao Q; Xu M; Jin Y; Dong L; Li Z; Yu D
Biochem Pharmacol; 2024 May; 223():116132. PubMed ID: 38492782
[TBL] [Abstract][Full Text] [Related]
17. Transient Receptor Potential Channels and Auditory Functions.
Ramkumar V; Sheth S; Dhukhwa A; Al Aameri R; Rybak L; Mukherjea D
Antioxid Redox Signal; 2022 Jun; 36(16-18):1158-1170. PubMed ID: 34465184
[No Abstract] [Full Text] [Related]
18. Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies.
Tang Q; Wang X; Jin H; Mi Y; Liu L; Dong M; Chen Y; Zou Z
Eur J Pharm Biopharm; 2021 Jun; 163():60-71. PubMed ID: 33775853
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Gpx4-mediated ferroptosis alleviates cisplatin-induced hearing loss in C57BL/6 mice.
Liu Z; Zhang H; Hong G; Bi X; Hu J; Zhang T; An Y; Guo N; Dong F; Xiao Y; Li W; Zhao X; Chu B; Guo S; Zhang X; Chai R; Fu X
Mol Ther; 2024 May; 32(5):1387-1406. PubMed ID: 38414247
[TBL] [Abstract][Full Text] [Related]
20. Protective role of edaravone against cisplatin-induced ototoxicity in an auditory cell line.
Im GJ; Chang J; Lee S; Choi J; Jung HH; Lee HM; Ryu SH; Park SK; Kim JH; Kim HJ
Hear Res; 2015 Dec; 330(Pt A):113-8. PubMed ID: 26278638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
